Promethazine improves antibiotic efficacy and disrupts biofilms of Burkholderia pseudomallei

References

• Adler NRL, Dean RE, Saint RJ, Stevens MP, Prior JL, Atkins TP, Galyov EE. 2013. Identification of a predicted trimeric autotransporter adhesin required for biofilm formation of Burkholderia pseudomallei. PLOS One. 8:e79461. doi:10.1371/journal.pone.007946110.1371/journal.pone.0079461
   Google Scholar
• Amaral L, Martins A, Spengler G, Molnar J. 2014. Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them. Front Pharmacol. 4:168.
   PubMed Web of Science ®Google Scholar
• Bandeira TJPG, Moreira CA, Brilhante RSN, Castelo-Branco DSCM, Neto MP, Cordeiro RA, Rodrigues TJS, Rocha MFG, Sidrim JJC. 2013. In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei. Antimicrob Agents Chemother. 57:5771–5773. doi:10.1128/AAC.00721-1310.1128/AAC.00721-13
   PubMed Web of Science ®Google Scholar
• Baugh S, Phillips CR, Ekanayaka AS, Piddock LJV, Webber MA. 2014. Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob Chemother. 69:673–681. doi:10.1093/jac/dkt42010.1093/jac/dkt420
   PubMed Web of Science ®Google Scholar
• Bhardwaj AK, Mohanty P. 2012. Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy. Recent Pat Antiinfect Drug Discov. 7:73–89. doi:10.2174/15748911279982971010.2174/157489112799829710
   PubMedGoogle Scholar
• Brilhante RSN, Valente LGA, Rocha MFG, Bandeira TJPG, Cordeiro RA, Lima RAC, Leite JJG, Ribeiro JF, Pereira JF, Castelo-Branco DSCM, Monteiro AJ, Sidrim JJC. 2012. Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei. Antimicrob Agents Chemother. 56:2198–2200. doi:10.1128/AAC.05885-1110.1128/AAC.05885-11
   PubMed Web of Science ®Google Scholar
• Castelo-Branco DSCM, Brilhante RSN, Paiva MAN, Teixeira CEC, Caetano EP, Ribeiro JF, Cordeiro RA, Sidrim JJC, Monteiro AJ, Rocha MFG. 2013. Azole-resistant Candida albicans from a wild Brazilian porcupine (Coendou prehensilis): a sign of an environmental imbalance? Med Mycol. 51:555–560. doi:10.3109/13693786.2012.75287810.3109/13693786.2012.752878
   PubMed Web of Science ®Google Scholar
• Castelo-Branco DSCM, Riello GB, Vasconcelos DC, Guedes GMM, Serpa R, Bandeira TJPG, Monteiro AJ, Cordeiro RA, Rocha MFG, Sidrim JJC, Brilhante RSN. 2016. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis. J Appl Microbiol. 120:600–606. doi:10.1111/jam.2016.120.issue-310.1111/jam.2016.120.issue-3
   PubMed Web of Science ®Google Scholar
• Chan YY, Chua KL. 2005. The Burkholderia pseudomallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J Bacteriol. 187:4707–4719. doi:10.1128/JB.187.14.4707-4719.200510.1128/JB.187.14.4707-4719.2005
   PubMed Web of Science ®Google Scholar
• Chan YY, Chua KL. 2010. Growth-related changes in intracellular spermidine and its effect on efflux pump expression and quorum sensing in Burkholderia pseudomallei. Microbiol. 156:1144–1154. doi:10.1099/mic.0.032888-010.1099/mic.0.032888-0
   PubMed Web of Science ®Google Scholar
• Chan YY, Tan TMC, Ong YM, Chua KL. 2004. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob Agents Chemother. 48:1128–1135. doi:10.1128/AAC.48.4.1128-1135.200410.1128/AAC.48.4.1128-1135.2004
   PubMed Web of Science ®Google Scholar
• Chan YY, Ong YM, Chua KL. 2007. Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob Agents Chemother. 51:623–630. doi:10.1128/AAC.01033-0610.1128/AAC.01033-06
   PubMed Web of Science ®Google Scholar
• CLSI. 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. CLSI document M45-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
   Google Scholar
• CLSI. 2012a. Methods for dilution and antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI document M7-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
   Google Scholar
• CLSI. 2012b. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute.
   Google Scholar
• Crowe A, McMahon N, Currie BJ, Baird RW. 2014. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory. Australia Int J Antimicrob Agents. 44:160–162. doi:10.1016/j.ijantimicag.2014.04.01210.1016/j.ijantimicag.2014.04.012
   PubMed Web of Science ®Google Scholar
• Dance D. 2014. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents. 43:310–318. doi:10.1016/j.ijantimicag.2014.01.00510.1016/j.ijantimicag.2014.01.005
   PubMed Web of Science ®Google Scholar
• Dastidar SG, Kristiansen JE, Molnar J, Amaral L. 2013. Role of phenothiazines and structurally similar compounds of plant origin in the fight against infections by drug resistant bacteria. Antibiotics. 2:58–72. doi:10.3390/antibiotics201005810.3390/antibiotics2010058
   Google Scholar
• Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersbøll BJ, Molin S. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Image Process. 146:2395–2407.
   Google Scholar
• Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332. doi:10.1016/j.ijantimicag.2009.12.01110.1016/j.ijantimicag.2009.12.011
   PubMed Web of Science ®Google Scholar
• Kvist M, Hancock V, Klemm P. 2008. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol. 74:7376–7382. doi:10.1128/AEM.01310-0810.1128/AEM.01310-08
   PubMed Web of Science ®Google Scholar
• Lamers RP, Cavallari JF, Burrows LL. 2013. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (paβn) permeabilizes the outer membrane of Gram-negative bacteria. PLOS ONE. 8:e60666. doi:10.1371/journal.pone.006066610.1371/journal.pone.0060666
   PubMed Web of Science ®Google Scholar
• Liew FY, Tay ST, Puthucheary SD. 2011. Reduced susceptibility of malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin. Trop Biomed. 28:646–650.
   PubMed Web of Science ®Google Scholar
• Limmathurotsakul D, Paeyao A, Wongratanacheewin S, Saiprom N, Takpho N, Thaipadungpanit J, Chantratita N, Wuthiekanun V, Day NP, Peacock SJ. 2014. Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis. Clin Microbiol Infect. 20:O854–6. doi:10.1111/1469-0691.1261410.1111/1469-0691.12614
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang L, Molin S. 2010. Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation. Antimicrob Agent Chemother. 54:3960–3963. doi:10.1128/AAC.00463-1010.1128/AAC.00463-10
   PubMed Web of Science ®Google Scholar
• Mima T, Schweizer HP. 2010. The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother. 54:3113–3120. doi:10.1128/AAC.01803-0910.1128/AAC.01803-09
   PubMed Web of Science ®Google Scholar
• Mima T, Schweizer HP, Xu ZQ. 2011. In vitro activity of cethromycin against Burkholderia pseudomallei and investigation of mechanism of resistance. J Antimicrob Chemother. 66:73–78. doi:10.1093/jac/dkq39110.1093/jac/dkq391
   PubMed Web of Science ®Google Scholar
• Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother. 43:465–470.
   PubMed Web of Science ®Google Scholar
• Peeters E, Nelis HJ, Coenye T. 2009. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother. 64:801–809. doi:10.1093/jac/dkp25310.1093/jac/dkp253
   PubMed Web of Science ®Google Scholar
• Podnecky NL, Wuthiekanun V, Peacock SJ, Schweizer HP. 2013. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates. Antimicrob Agents Chemother. 57:4381–4386. doi:10.1128/AAC.00660-1310.1128/AAC.00660-13
   PubMed Web of Science ®Google Scholar
• Sarker SD, Nahar L, Kumarasamy Y. 2007. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods. 42:321–324. doi:10.1016/j.ymeth.2007.01.00610.1016/j.ymeth.2007.01.006
   PubMed Web of Science ®Google Scholar
• Schweizer HP. 2012. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Fut Microbiol. 7:1389–1399. doi:10.2217/fmb.12.11610.2217/fmb.12.116
   PubMed Web of Science ®Google Scholar
• Solano C, Echeverz M, Lasa I. 2014. Biofilm dispersion and quorum sensing. Curr Opin Microbiol. 18:96–104. doi:10.1016/j.mib.2014.02.00810.1016/j.mib.2014.02.008
   PubMed Web of Science ®Google Scholar
• Soto SM. 2013. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence. 4:223–229. doi:10.4161/viru.2372410.4161/viru.23724
   PubMed Web of Science ®Google Scholar
• Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. 2004. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother. 54:1134–1138. doi:10.1093/jac/dkh47110.1093/jac/dkh471
   PubMed Web of Science ®Google Scholar
• Viveiros M, Amaral L. 2001. Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines. Int J Antimicrob Agents. 17:225–228. doi:10.1016/S0924-8579(00)00343-510.1016/S0924-8579(00)00343-5
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Currie BJ, Peacock SJ. 2012. Melioidosis. N Engl J Med. 367:1035–1044. doi:10.1056/NEJMra120469910.1056/NEJMra1204699
   PubMed Web of Science ®Google Scholar
• Yamasaki S, Wang LY, Hirata T, Hayashi-Nishino M, Nishino K. 2015. Multidrug efflux pumps contribute to Escherichia coli biofilm maintenance. Int J Antimicrob Agents. 45:439–441. doi:10.1016/j.ijantimicag.2014.12.00510.1016/j.ijantimicag.2014.12.005
   PubMed Web of Science ®Google Scholar